Patents Assigned to Merck Patents GmbH
  • Publication number: 20190280218
    Abstract: The invention relates to materials, to electroluminescence devices comprising said materials and to the use thereof.
    Type: Application
    Filed: May 22, 2019
    Publication date: September 12, 2019
    Applicant: Merck Patent GmbH
    Inventors: AMIR HOSSAIN PARHAM, Arne Buesing, Philipp Stoessel, Anja Gerhard, Christof Pflumm, Thomas Eberle, Anja Jatsch, Jonas Valentin Kroeber, Lars Dobelmann-Mara
  • Publication number: 20190276477
    Abstract: Metal complexes including cyclopentadienyl ligands and methods of using such metal complexes to prepare metal-containing films are provided.
    Type: Application
    Filed: November 3, 2017
    Publication date: September 12, 2019
    Applicant: MERCK PATENT GMBH
    Inventors: Ming FANG, Joby ELDO, Charles DEZELAH, Daniel MOSER, Ravi KANJOLIA
  • Patent number: 10407394
    Abstract: The invention relates to a heteroaryl compound according to formula (I) and to the use thereof in electronic devices.
    Type: Grant
    Filed: September 5, 2014
    Date of Patent: September 10, 2019
    Assignee: Merck Patent GmbH
    Inventors: Amir Hossain Parham, Philipp Stoessel, Thomas Eberle, Anja Jatsch, Jonas Valentin Kroeber, Christof Pflumm, Irina Martynova, Frank Voges, Frank Stieber
  • Patent number: 10407384
    Abstract: The present invention relates to compounds which are suitable as synthesis precursors for the production of electronically active materials for use in organic electroluminescence devices.
    Type: Grant
    Filed: June 27, 2017
    Date of Patent: September 10, 2019
    Assignee: Merck Patent GmbH
    Inventors: Philipp Stoessel, Amir Hossain Parham, Anja Jatsch
  • Patent number: 10411190
    Abstract: The invention relates to novel organic semiconducting compounds containing a polycyclic unit, to methods for their preparation and educts or intermediates used therein, to compositions, polymer blends and formulations containing them, to the use of the compounds, compositions and polymer blends as organic semiconductors in, or for the preparation of, organic electronic (OE) devices, especially organic photovoltaic (OPV) devices, perovskite-based solar cell (PSC) devices, organic photo-detectors (OPD), organic field effect transistors (OFET) and organic light emitting diodes (OLED), and to OE, OPV, PSC, OPD, OFET and OLED devices comprising these compounds, compositions or polymer blends.
    Type: Grant
    Filed: October 4, 2017
    Date of Patent: September 10, 2019
    Assignee: Merck Patent GmbH
    Inventors: Graham Morse, Lana Nanson, William Mitchell, Michal Krompiec, Mansoor D'Lavari, Agnieszka Pron
  • Publication number: 20190270768
    Abstract: The invention relates to a process for the production of amide bonds, in particular peptide bonds, with the aid of novel amide linking reagents containing an anion of the formula (I), to the novel reagents, and to the preparation thereof.
    Type: Application
    Filed: November 6, 2017
    Publication date: September 5, 2019
    Applicant: Merck Patent GmbH
    Inventors: Nikolai (Mykola) IGNATYEV, Walter FRANK, Peter BARTHEN, Myroslav VYSOTSKY
  • Publication number: 20190270932
    Abstract: The present invention relates to a light luminescent particle comprising a nanosized light emitting material, and use of said light luminescent particle. The present invention further relates to a composition comprising a light luminescent particle, an optical medium, and an optical device. The present invention also relates to method for preparing of said luminescent particle.
    Type: Application
    Filed: November 8, 2017
    Publication date: September 5, 2019
    Applicant: Merck Patent GmbH
    Inventor: Arjan MEIJER
  • Patent number: 10400169
    Abstract: The invention relates to a liquid-crystalline medium which comprises at least one compound of the formula I, in which R1, R1*, Z1, Z2 and L1-3 have the meanings defined herein, and to the use thereof for an active-matrix display, in particular based on the VA, PSA, PS-VA, PALC, FFS, PS-FFS, PS-IPS or IPS effect.
    Type: Grant
    Filed: October 28, 2016
    Date of Patent: September 3, 2019
    Assignee: MERCK PATENT GMBH
    Inventors: Harald Hirschmann, Monika Bauer, Martina Windhorst, Marcus Reuter, Constanze Brocke, Rocco Fortte, Matthias Bremer, Sabine Schoen
  • Patent number: 10399957
    Abstract: The present invention relates to compounds of Formula I and pharmaceutically acceptable compositions thereof, useful as TLR7/8 antagonists.
    Type: Grant
    Filed: December 16, 2016
    Date of Patent: September 3, 2019
    Assignee: Merck Patent GmbH
    Inventors: Brian A. Sherer, Nadia Brugger
  • Patent number: 10403833
    Abstract: The present invention relates inter alia to novel organic metal complexes comprising, e.g., platinum and specific side groups, their preparation und their use in electronic devices.
    Type: Grant
    Filed: July 14, 2017
    Date of Patent: September 3, 2019
    Assignee: Merck Patent GmbH
    Inventors: Rèmi Manouk Anémian, Noriyuki Matsuda
  • Publication number: 20190265219
    Abstract: The invention relates to a method for determining ammonium or ammonia in aqueous samples in accordance with the known Berthelot method, wherein the risk of incorrectly low results is greatly reduced by additionally measuring the extinction in the absorption range of the nitroprusside used as a catalyst.
    Type: Application
    Filed: September 18, 2017
    Publication date: August 29, 2019
    Applicant: MERCK PATENT GMBH
    Inventor: Ralf OLT
  • Publication number: 20190264105
    Abstract: The present invention relates to a liquid crystal (LC) medium comprising polymerisable compounds, to a process for its preparation, to its use for optical, electro-optical and electronic purposes, in particular in LC displays, and to LC displays comprising it.
    Type: Application
    Filed: October 16, 2017
    Publication date: August 29, 2019
    Applicant: MERCK PATENT GMBH
    Inventors: Nils GREINERT, Matthias BREMER, Patrick SUESS, Christian SCHOENEFELD, Jochen SIEBERLING, Renate SEEGER, Anna Lisa HAWLITSCHEK
  • Patent number: 10392561
    Abstract: The invention relates to bimesogenic compounds of formula I wherein R11, R12, MG11, MG12, X11, X12 and Sp1 have the meaning given in claim 1, to the use of bimesogenic compounds of formula I in liquid crystal media and particular to flexoelectric liquid crystal devices comprising a liquid crystal medium according to the present invention.
    Type: Grant
    Filed: December 8, 2015
    Date of Patent: August 27, 2019
    Assignee: Merck Patent GmbH
    Inventors: Detlef Pauluth, Kevin Adlem, Owain Llyr Parri, Rachel Tuffin, Hassan Arasi, Patricia Eileen Saxton
  • Patent number: 10392332
    Abstract: The present invention relates to novel compounds containing fluorinated end groups, to the use thereof as surface-active substances, and to compositions comprising these compounds.
    Type: Grant
    Filed: July 15, 2015
    Date of Patent: August 27, 2019
    Assignee: MERCK PATENT GmbH
    Inventors: Reiner Friedrich, Gerhard Jonschker
  • Patent number: 10396297
    Abstract: The present application relates to a material comprising a monoarylamine of a defined formula and a p-dopant of a defined formula. The present application further relates to the use of said material in an organic layer of an electronic device, the device preferably being an organic electroluminescent device (OLED).
    Type: Grant
    Filed: September 25, 2015
    Date of Patent: August 27, 2019
    Assignee: Merck Patent GmbH
    Inventors: Frank Voges, Frank Stieber, Philipp Stoessel, Teresa Mujica-Fernaud, Christof Pflumm, Joachim Kaiser
  • Patent number: 10391418
    Abstract: The present invention relates to a process for the vacuum purification of chemical compounds and to an apparatus for carrying out this process.
    Type: Grant
    Filed: March 5, 2018
    Date of Patent: August 27, 2019
    Assignee: Merck Patent GmbH
    Inventors: Philipp Stossel, Juergen Fuchs
  • Patent number: 10392375
    Abstract: The present invention relates to compounds of Formula I and pharmaceutically acceptable compositions thereof, useful as IRAK inhibitors.
    Type: Grant
    Filed: April 23, 2018
    Date of Patent: August 27, 2019
    Assignee: Merck Patent GmbH
    Inventors: Catherine Jorand-Lebrun, Ruoxi Lan, Austin Chen, Ryan C. Clark
  • Publication number: 20190256499
    Abstract: Substituted quinoxaline derivatives are useful for the prevention and/or treatment of medical conditions known as hyperproliferative diseases. The compounds are also useful for medical conditions that are affected by inhibiting 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase (PFKFB). Further, the compounds are useful for the prevention and/or treatment of cancer.
    Type: Application
    Filed: November 6, 2017
    Publication date: August 22, 2019
    Applicant: Merck Patent GmbH
    Inventor: Hans-Peter Buchstaller
  • Publication number: 20190256777
    Abstract: The present invention relates to polymerizable compounds, to processes and intermediates for the preparation thereof, to liquid-crystal media comprising them, and to the use of the polymerizable compounds and liquid crystalline media for optical, electro-optical and electronic purposes, in particular in liquid crystalline displays, especially in liquid crystalline displays of the polymer sustained alignment type.
    Type: Application
    Filed: May 1, 2019
    Publication date: August 22, 2019
    Applicant: MERCK PATENT GMBH
    Inventors: Qiong TONG, Nico SCHWEBEL, Constanze BROCKE, Kaja DEING, Julian VOGT, Elisabeth MEYER
  • Publication number: 20190256819
    Abstract: The present invention relates to a process for improving the solubility or dissolution behaviour of components in an aqueous solution. The dissolution properties of a slowly/badly dissolving component can be positively affected by generating mixed particles of this component with another component which has a negative dissolution enthalpy. By preparing and adding such mixed particles solubility is improved without changing the chemical composition.
    Type: Application
    Filed: July 25, 2017
    Publication date: August 22, 2019
    Applicant: Merck Patent GmbH
    Inventors: Joerg VON HAGEN, Andrew SALAZAR, Markus LUBDA